Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 4/20 | 0.64 |
| ▸ | NPC1 | O15118 | 2/20 | 0.64 |
| ▸ | POLB | P06746 | 1/20 | 0.55 |
| ▸ | PKM | P14618 | 1/20 | 0.55 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.50 |
| ▸ | USP2 | O75604 | 2/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 2/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.49 |
| ▸ | MAPT | P10636 | 1/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.49 |
| ▸ | LMNA | P02545 | 1/20 | 0.49 |
| ▸ | THRB | P10828 | 1/20 | 0.49 |
| ▸ | RECQL | P46063 | 1/20 | 0.48 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.46 |
| ▸ | NCOA1 | Q15788 | 1/20 | 0.46 |
| ▸ | NCOA3 | Q9Y6Q9 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13738136 | 0.78 | GAA (1.00) | GAANPC1POLBPKMALOX15 | |
| SCHEMBL19820836 | 0.78 | POLB (0.54) | GAANPC1POLBPKMALOX15 | |
| SCHEMBL12462229 | 0.76 | CYP3A4 (0.45) | GAANPC1POLBALOX15KMT2A | |
| SCHEMBL8138380 | 0.76 | GAA (0.69) | GAANPC1POLBPKMALOX15 | |
| SCHEMBL4468905 | 0.75 | POLB (0.53) | GAANPC1POLBPKMALOX15 | |
| SCHEMBL4471243 | 0.73 | MEN1 (0.53) | GAANPC1POLBPKMALOX15 | |
| SCHEMBL6128205 | 0.73 | POLB (0.49) | GAANPC1POLBPKMALOX15 | |
| SCHEMBL3216284 | 0.73 | GAA (0.50) | GAANPC1POLBPKMALOX15 | |
| SCHEMBL4468900 | 0.71 | RECQL (0.53) | GAANPC1POLBPKMALOX15 | |
| SCHEMBL5456606 | 0.70 | NPC1 (0.64) | NPC1KMT2ASMN1; SMN2MEN1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 82 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120027698-A9 | COSMETIC AND/OR PHARMACEUTICAL COMPOSITION COMPRISING AT LEAST ONE COPOLYMER COMPRISING AT LEAST ONE IONIZABLE GROUP, AND COSMETIC TREATMENT PROCESS | L'OREAL S.A. | 2012-02-02 | — | — | US | claimed |
| US-20100278764-A1 | COSMETIC AND/OR PHARMACEUTICAL COMPOSITION COMPRISING AT LEAST ONE COPOLYMER COMPRISING AT LEAST ONE IONIZABLE GROUP, AND COSMETIC TREATMENT PROCESS | L'OREAL S.A. | 2010-11-04 | — | — | US | claimed |
| US-20070264208-A1 | Cosmetic and/or pharmaceutical composition comprising at least one copolymer comprising at least one ionizable group, and cosmetic treatment process | L'OREAL S.A. (FR) | 2007-11-15 | — | — | US | claimed |
| EP-1797867-A1 | Cosmetic or pharmaceutical composition comprising a copolymer containing at least one ionisable group, and cosmetic treatment | L'Oréal (FR) | 2007-06-20 | — | — | EP | claimed |
| US-12522534-B2 | Self-healing optical fibers and the compositions used to create the same | COVESTRO (NETHERLANDS) B.V. (NL) | 2026-01-13 | — | — | US | disclosed |
| US-12491704-B2 | Multi-layered optical devices | COVESTRO (NETHERLANDS) B.V. (NL) | 2025-12-09 | — | — | US | disclosed |
| EP-4127794-B1 | SELF-HEALING OPTICAL FIBERS AND THE COMPOSITIONS USED TO CREATE THE SAME | COVESTRO NETHERLANDS BV (NL) | 2025-12-03 | — | — | EP | disclosed |
| US-12473395-B2 | Self-healing oligomers and the use thereof | COVESTRO (NETHERLANDS) B.V. (NL) | 2025-11-18 | — | — | US | disclosed |
| US-20230117457-A1 | METHODS OF SYNTHESIZING MULTI-HYDROGEN BONDING OLIGOMERS | COVESTRO (NETHERLANDS) B.V. (NL) | 2023-04-20 | — | — | US | disclosed |
| US-20230120588-A1 | SELF-HEALING OLIGOMERS AND THE USE THEREOF | COVESTRO (NETHERLANDS) B.V. (NL) | 2023-04-20 | — | — | US | disclosed |
| US-20230116356-A1 | MULTI-LAYERED OPTICAL DEVICES | COVESTRO (NETHERLANDS) B.V. (NL) | 2023-04-13 | — | — | US | disclosed |
| EP-4126542-A1 | MULTI-LAYERED OPTICAL DEVICES | Covestro (Netherlands) B.V. (NL) | 2023-02-08 | — | — | EP | disclosed |
| WO-2010146147-A2 | COMPOSITION FOR TREATING KERATIN FIBRES COMPRISING A BLOCK COPOLYMER, A SILOXANE RESIN AND A VOLATILE SOLVENT | L'OREAL (FR) | 2010-12-23 | — | — | WO | disclosed |
| US-20100278764-A1 | COSMETIC AND/OR PHARMACEUTICAL COMPOSITION COMPRISING AT LEAST ONE COPOLYMER COMPRISING AT LEAST ONE IONIZABLE GROUP, AND COSMETIC TREATMENT PROCESS | L'OREAL S.A. | 2010-11-04 | — | — | US | disclosed |
| US-20100154134-A1 | COMPOSITION FOR DYEING KERATIN FIBERS, COMPRISING AT LEAST ONE POLYALKENE-BASED SUPRAMOLECULAR POLYMER, AT LEAST ONE PIGMENT AND AT LEAST ONE VOLATILE SOLVENT | L'OREAL S.A. (FR) | 2010-06-24 | — | — | US | disclosed |
| US-20100158832-A1 | COSMETIC COMPOSITION COMPRISING A SUPRAMOLECULAR POLYMER AND METHOD FOR MAKING UP THE SKIN AND/OR LIPS EMPLOYING A COMPOSITION COMPRISNG A SUPRAMOLECULAR POLYMER | L'OREAL S.A. (FR) | 2010-06-24 | — | — | US | disclosed |
| WO-2010057920-A2 | METHOD FOR MAKING UP OR CARING FOR EYELASHES OR EYEBROWS USING A POLYALKENE-BASED SUPRAMOLECULAR POLYMER | L'OREAL (FR) | 2010-05-27 | — | — | WO | disclosed |
| US-20070264208-A1 | Cosmetic and/or pharmaceutical composition comprising at least one copolymer comprising at least one ionizable group, and cosmetic treatment process | L'OREAL S.A. (FR) | 2007-11-15 | — | — | US | disclosed |
| US-20070189991-A1 | Cosmetic compositon comprising a (Thio)urethane/ (thio)urea copolymer capable of forming at least 3 hydrogen bonds, and a method of cosmetic treatment | L'OREAL S.A. (FR) | 2007-08-16 | — | — | US | disclosed |
| EP-1797867-A1 | Cosmetic or pharmaceutical composition comprising a copolymer containing at least one ionisable group, and cosmetic treatment | L'Oréal (FR) | 2007-06-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070189991-A1 | Cosmetic compositon comprising a (Thio)urethane/ (thio)urea copolymer capable of forming at least 3 hydrogen bonds, and a method of cosmetic treatment | KRT18, TST, CTH | GAA 2708/4885NPC1 4772/4885POLB 625/4885 |
| US-20100158832-A1 | COSMETIC COMPOSITION COMPRISING A SUPRAMOLECULAR POLYMER AND METHOD FOR MAKING UP THE SKIN AND/OR LIPS EMPLOYING A COMPOSITION COMPRISNG A SUPRAMOLECULAR POLYMER | CUTA, PARG, DSG1 | GAA 1595/4885NPC1 3433/4885POLB 230/4885 |
| US-20070264208-A1 | Cosmetic and/or pharmaceutical composition comprising at least one copolymer comprising at least one ionizable group, and cosmetic treatment process | KRT18, DSG1, DSC1 | GAA 1408/4885NPC1 3377/4885POLB 960/4885 |
| US-20100154134-A1 | COMPOSITION FOR DYEING KERATIN FIBERS, COMPRISING AT LEAST ONE POLYALKENE-BASED SUPRAMOLECULAR POLYMER, AT LEAST ONE PIGMENT AND AT LEAST ONE VOLATILE SOLVENT | KRT18, JUP, DSG1 | GAA 4294/4885NPC1 4230/4885POLB 972/4885 |
| US-20120027698-A9 | COSMETIC AND/OR PHARMACEUTICAL COMPOSITION COMPRISING AT LEAST ONE COPOLYMER COMPRISING AT LEAST ONE IONIZABLE GROUP, AND COSMETIC TREATMENT PROCESS | KRT18, DSG1, DSC1 | GAA 1243/4885NPC1 3503/4885POLB 775/4885 |
| US-20100278764-A1 | COSMETIC AND/OR PHARMACEUTICAL COMPOSITION COMPRISING AT LEAST ONE COPOLYMER COMPRISING AT LEAST ONE IONIZABLE GROUP, AND COSMETIC TREATMENT PROCESS | KRT18, DSG1, DSC1 | GAA 1243/4885NPC1 3503/4885POLB 775/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.